Dapagliflozin (10mg) + Glimepiride (2mg) + Metformin HCl (1000mg) ER is a triple-combination, extended-release (ER) tablet for managing Type 2 Diabetes by lowering blood sugar through multiple mechanisms: Dapagliflozin removes sugar via kidneys, Glimepiride boosts insulin from the pancreas, and Metformin reduces sugar production/absorption and increases insulin sensitivity, often used for better glycemic control and reducing heart risks. This specific formulation (10/2/1000mg) provides a potent, sustained release for improved blood sugar management in adults.
